BSEM BioStem Technologies, Inc.
$1.54▼ -1.91%
Healthcare
Other
Volume 169.3K
Avg Volume (10D) 130.3K
Key Metrics & Fundamentals
Market Cap
$28.76M
P/E Ratio
1.8
Div Yield
0.00%
52W Range
1.40 - 8.40
% vs 50 MA
-52.43%
% vs 200 MA
-63.94%
RSI-14
26.4
MACD Histogram
-0.0500
Beta (1Y vs SPY)
1.23
Gross Rev
$7.90M
Gross Profit
$4.84M
EBITDA
-$7.71M
COGS
$3.06M
Operating Exp
$13.24M
Operating Income
-$8.40M
EBIT
-$8.40M
Pretax Income
-$8.97M
Net Income
-$8.97M
EPS (Diluted)
-0.52
Price & Volume History
Loading chart…
Recent News

BioStem Technologies’ CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options
GlobeNewswire · Oct 8, 2026 7:00 AM ET

BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
GlobeNewswire · Oct 1, 2026 7:00 AM ET

BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire · Sep 30, 2026 8:00 AM ET
Terminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ: BSEM) has joined the Terminal1 platform
GlobeNewswire · Sep 21, 2026 4:30 PM ET

BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
GlobeNewswire · Sep 18, 2026 7:00 AM ET

BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier
GlobeNewswire · Sep 4, 2026 7:00 AM ET

BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 3, 2026 4:05 PM ET

BioStem Technologies Eyes Surgical Growth, Manufacturing Shift After BioTissue Deal
MarketBeat · Aug 21, 2026 9:01 PM ET

Sidoti Events, LLC's August Micro-Cap Virtual Conference
ACCESS Newswire · Aug 18, 2026 10:00 AM ET

BioStem Technologies to Present at the Sidoti MicroCap Conference
GlobeNewswire · Aug 14, 2026 4:05 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See BSEM's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.